Breakthrough drug co-developed by Hong Kong research team offers hope of longer life to brain cancer sufferers
Wang Jiguang (left), assistant professor at the division of life science, department of chemical and biological engineering, HKUST, and Professor Jiang Tao (right) from Beijing Tiantan Hospital, showing results of the clinical trial. Photo: Hong…
2018 USCACA-AFCR Young Investigator Award
The 2018 USCACA-AFCR Scholar Award Ceremony in Tianjin on November 17, 2018 The Asian Fund for Cancer Research and the US Chinese Anti-Cancer Association have jointly awarded six outstanding Chinese cancer researchers in the early…
USCACA & AFCR 2018 Scholar Awards
The United States Chinese Anti-Cancer Association and AFCR are pleased to invite nominations for the USCACA-AFCR 2018 Scholar Awards. The Awards will recognize 4 to 5 junior Chinese investigators on the basis of significant contributions…
AFCR April 2018 China Brain Cancer Round Table
(clockwise) AFCR Founder and CEO Dr. Sujuan Ba, ECI Founder Mr. Andrew Forrest and PhIRDA Executive President Mr. Song Ruilin Bringing International Partners Together In recent months, the Asian Fund for Cancer Research (AFCR)…
Two Giants of Cancer Care® with AFCR Affiliation
Respected healthcare professionals who are advancing the field of oncology by their contributions in research and clinical practice were recognized on June 31st as Giants of Cancer Care in an event at the Adler Planetarium…